Australia markets closed

GeneDx Holdings Corp. (WGS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
28.78+0.01 (+0.03%)
At close: 04:00PM EDT
28.50 -0.28 (-0.97%)
After hours: 07:06PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
231,145
202,566
234,694
212,195
179,322
-
Cost of revenue
244,375
112,560
261,444
228,797
175,296
-
Gross profit
-13,230
90,006
-26,750
-16,602
4,026
-
Operating expenses
Research development
84,083
58,266
86,203
105,162
72,700
-
Selling general and administrative
354,398
194,711
338,242
318,726
163,925
-
Total operating expenses
445,320
260,200
430,757
429,547
246,020
-
Operating income or loss
-458,550
-170,194
-457,507
-446,149
-241,994
-
Interest expense
3,111
-
3,207
2,835
2,474
783
Total other income/expenses net
130,688
-7,613
-139,859
203,515
2,622
-
Income before tax
-329,546
-176,693
-598,032
-245,390
-241,340
-
Income tax expense
-49,142
-926
-49,052
0
0
-
Income from continuing operations
-280,404
-175,767
-548,980
-245,390
-241,340
-
Net income
-280,404
-175,767
-548,980
-245,390
-241,340
-
Net income available to common shareholders
-280,404
-175,767
-548,980
-245,390
-241,340
-
Basic EPS
-35.44
-7.23
-53.63
-74.91
-33.16
-
Diluted EPS
-35.44
-7.23
-53.63
-74.91
-33.16
-
Basic average shares
20,764
24,312
10,237
3,275
7,278
-
Diluted average shares
20,764
24,312
10,237
3,275
7,278
-